Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αvβ3 and/or αvβ5 integrin.
-
Page 28-29
(2010/02/07)
More Articles about upstream products of 381226-47-7